NCT01750567 2025-09-09
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
University of Michigan Rogel Cancer Center
Phase 2 Completed
Clinical Trials
10 trialsNCT03200015 2022-11-07
Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma
Hospital Universitario Dr. Jose E. Gonzalez
Phase 2 Completed
NCT02531308 2022-09-28
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT03600363 2020-03-11
A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients
Ruijin Hospital
Phase 2 Unknown
NCT02815397 2017-11-17
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT01324180 2017-08-07
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03118128 2017-07-06
Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase NA Completed
NCT01486043 2015-01-30
Metformin and Transient Hyperglycemia
Children's Hospital Los Angeles
Phase NA Terminated
NCT00659568 2013-05-30
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed